Distribution patterns of cannabinoid CB1 receptors in the hippocampus of APPswe/PS1ΔE9 double transgenic mice

Brain Research

Volumn 1376, Issue , 2011, Pages 94-100

  Kalifa, Sara ^a,b   Polston, Eva K ^a   Allard, Joanne S ^a   Manaye, Kebreten F ^a  

^a HOWARD UNIVERSITY   (United States)

^b GEORGE MASON UNIVERSITY   (United States)

Author keywords

Alzheimer's disease; Astrocytes; Inflammation; iNOS; TNF

Indexed keywords

AMYLOID PRECURSOR PROTEIN; CANNABINOID 1 RECEPTOR; INDUCIBLE NITRIC OXIDE SYNTHASE; PRESENILIN 1; TUMOR NECROSIS FACTOR ALPHA;

ALZHEIMER DISEASE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL COUNT; CELL PROLIFERATION; CONTROLLED STUDY; GENOTYPE; HIPPOCAMPUS; IMMUNOREACTIVITY; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; TRANSGENIC MOUSE;

ALZHEIMER DISEASE; AMYLOID BETA-PROTEIN PRECURSOR; ANIMALS; ASTROCYTES; BLOTTING, WESTERN; DISEASE MODELS, ANIMAL; HIPPOCAMPUS; IMMUNOHISTOCHEMISTRY; MALE; MICE; MICE, TRANSGENIC; NEURONS; NITRIC OXIDE SYNTHASE TYPE II; PRESENILIN-1; RECEPTOR, CANNABINOID, CB1; TUMOR NECROSIS FACTOR-ALPHA;

MUS; MUS MUSCULUS;

EID: 79851509826     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.brainres.2010.12.061     Document Type: Article

References (56)

1. D. Baker, G. Pryce, J.L. Croxford, P. Brown, R.G. Pertwee, J.W. Huffman, and L. Layward Cannabinoids control spasticity and tremor in a multiple sclerosis model Nature 404 2000 84 87 (Pubitemid 30143137)
2. W.A. Devane, L. Hanus, A. Breuer, R.G. Pertwee, L.A. Stevenson, G. Griffin, D. Gibson, A. Mandelbaum, A. Etinger, and R. Mechoulam Isolation and structure of a brain constituent that binds to the cannabinoid receptor Science 258 5090 1992 1946 1949 (Pubitemid 23026736)
3. V. Di Marzo, and D.G. Deutsch Endocannabinoids: endogenous cannabinoid receptor ligands with neuromodulatory action Trends Neurosci. 21 12 1998 521 528 Review. Erratum in: Trends Neurosci. 22 2 1999 80 Feb (Pubitemid 28555694)
4. V. Di Marzo, C.S. Breivogel, Q. Tao, D.T. Bridgen, R.K. Razdan, A.M. Zimmer, A. Zimmer, and B.R. Martin Levels, metabolism, and pharmacological activity of anandamide in CB(1) cannabinoid receptor knockout mice: evidence for non-CB(1), non-CB(2) receptor-mediated actions of anandamide in mouse brain J. Neurochem. 75 2000 2434 2444
5. M. Egertova, and M.R. Elphick Localisation of cannabinoid receptors in the rat brain using antibodies to the intracellular C-terminal tail of CB J. Comp. Neurol. 422 2000 159 171 (Pubitemid 30390161)
6. P. Eikelenboom, S.S. Zhan, W.A. van Gool, and D. Allsop Inflammatory mechanisms in Alzheimer's disease Trends Pharmacol. Sci. 15 1994 447 450 (Pubitemid 24379277)
7. L.F. Eng, and R.S. Ghirnikar GFAP and astrogliosis Brain Pathol. 4 1994 229 237 (Pubitemid 24261929)
8. S. Galiegue, S. Mary, J. Marchand, D. Dussossory, D. Carriere, P. Carayon, M. Bouaboula, D. Shire, G. Le Fur, and P. Casellas Expression of central and peripheral cannabinoid receptors in human immune tissues and leukocyte subpopulations Eur. J. Biochem. 232 1995 54 61
9. D. Games, D. Adams, R. Alessandrini, R. Barbour, P. Berthelette, C. Blackwell, T. Carr, J. Clemens, T. Donaldson, and F. Gillespie Alzheimer-type neuropathology in transgenic mice overexpressing V717F beta-amyloid precursor protein Nature 373 1995 523 527
10. M. Glass, R.L. Faull, and M. Dragunow Loss of cannabinoid receptors in the substantia nigra in Huntington's disease Neuroscience 56 1993 523 527 (Pubitemid 23290567)
11. H.J. Gundersen, E.B. Jensen, K. Kiêu, and J. Nielsen The efficiency of systematic sampling in stereology-reconsidered J. Microsc. 193 1999 199 211
12. H.J. Gundersen Stereology of arbitrary particles. A review of unbiased number and size estimators and the presentation of some new ones, in memory of William R. Thompson J. Microsc. 143 1986 3 45
13. A.J. Hampson, M. Grimaldi, J. Axelrod, and D. Wink Cannabidiol and (-)Δ9-tetrahydrocannabinol are neuroprotective antioxidants Med. Sci. 95 1998 8268 8273 (Pubitemid 28326102)
14. J. Hardy Amyloid, the presenilins and Alzheimer's disease Trends Neurosci. 20 1997 154 159 (Pubitemid 27116286)
15. M. Herkenham, A.B. Lynn, M.R. Johnson, L.S. Melvin, B.R. de Costa, and K.C. Rice Characterization and localization of cannabinoid receptors in rat brain: a quantitative in vitro autoradiographic study J. Neurosci. 11 1991 563 583
16. K.K. Hsiao, D.R. Borchelt, K. Olson, R. Johannsdottir, C. Kitt, W. Yunis, S. Xu, C. Eckman, S. Younkin, and D. Price Age-related CNS disorder and early death in transgenic FVB/N mice overexpressing Alzheimer amyloid precursor proteins Neuron 15 1995 1203 1218
17. S. Itagaki, P.L. McGeer, H. Akiyama, S. Zhu, and D. Selkoe Relationship of microglia and astrocytes to amyloid deposits of Alzheimer disease J. Neuroimmunol. 24 1989 173 182 (Pubitemid 19271472)
18. K. Johnson-Wood, M. Lee, R. Motter, K. Hu, G. Gordon, R. Barbour, K. Khan, M. Gordon, H. Tan, D. Games, I. Lieberburg, D. Schenk, P. Seubert, and L. McConlogue Amyloid precursor protein processing and AB42 deposition in a transgenic mouse model of Alzheimers disease Proc. Natl Acad. Sci. 94 1997 1550 1555
19. D.L. Lei, J.M. Long, J. Hengemihle, J. O'Neill, K.F. Manaye, D.K. Ingram, and P.R. Mouton Effects of estrogen and raloxifene on neuroglia number and morphology in the hippocampus of aged female mice Neuroscience 121 2003 659 666 (Pubitemid 38367505)
20. Y. Liu, M.J. Yoo, A. Savonenko, W. Stirling, D.L. Price, D.R. Borchelt, L. Mamounas, W.E. Lyons, M.E. Blue, and M.K. Lee Amyloid pathology is associated with progressive monoaminergic neurodegeneration in a transgenic mouse model of Alzheimer's disease J. Neurosci. 28 2008 13805 13814
21. P. Liu, D.K. Bilkey, C.L. Darlington, and P.F. Smith Cannabinoid CB1 receptor protein expression in the rat hippocampus and entorhinal, perirhinal, postrhinal and temporal cortices: regional variations and age-related changes Brain Res. 979 2003 235 239 (Pubitemid 36792176)
22. H.J. Lüth, G. Münch, and T. Arendt V Aberrant expression of NOS isoforms in Alzheimer's disease is structurally related to nitrotyrosine formation Brain Res. 953 1-2 2002 135 143 Oct 25 (Pubitemid 35217815)
23. X.R. Lu, W.Y. Ong, and K. Mackie A light and electron microscopic study of the CB1 cannabinoid receptor in primate brain Neuroscience 92 1999 1177 1191 (Pubitemid 29292558)
24. P. Mailleux, and J.J. Vanderhaeghen Distribution of neuronal cannabinoid receptor in the adult rat brain: a comparative receptor binding radioautography and in situ hybridization histochemistry Neuroscience 48 1992 655 668
25. P. Malherbe, J.G. Richards, J.R. Martin, H. Bluethmann, J. Maqqio, and G. Huber Lack of beta-amyloidosis in transgenic mice expressing low levels of familial Alzheimer's disease missense mutations Neurobiol. Aging 17 1996 205 214 (Pubitemid 26171512)
26. ΔE9 neuroimaging, stereology, and biochemistry AGE 29 2007 87 96 (Pubitemid 350112202)
27. Y. Marchalant, F. Cerbai, H.M. Brothers, and G.L. Wenk Anti-inflammatory property of the cannabinoid agonist WIN-55212-2 in a rodent model of chronic brain inflammation Feb 23 Neuroscience 144 4 2007 1516 1522 Epub 2006 Dec 18 (Pubitemid 46123810)
28. G. Marsicano, B. Moosmann, H. Hermann, B. Lutz, and C. Behl Neuroprotective properties of cannabinoids against oxidative stress: role of the cannabinoid receptor CB1 J. Neurochem. 80 2002 448 456 (Pubitemid 36383028)
29. L.A. Matsuda Molecular aspects of cannabinoid receptors Crit. Rev. Neurobiol. 11 1997 143 166 (Pubitemid 27453168)
30. L.A. Matsuda, S.J. Loliat, M.J. Brownstein, A.C. Young, and T.I. Bonner Structure of a cannabinoid receptor and functional expression of the cloned cDNA Nature 346 1990 561 564
31. P.L. McGeer, and E.G. McGeer The inflammatory response system of brain: implications for therapy of Alzheimer and other neurodegenerative diseases Brain Res. Rev. 21 1995 195 218 (Pubitemid 26061873)
32. R. Mechoulam, S. Ben-Shabat, L. Hanus, M. Ligumsky, N.E. Kaminski, A.R. Schatz, A. Gopher, S. Almog, B.R. Martin, and D.R. Compton Identification of an endogenous 2-monoglyceride, present in canine gut, that binds to cannabinoid receptors Biochem. Pharmacol. 50 1 1995 83 90
33. R. Mechoulam, D. Panikashvili, and E. Shohami Cannabinoids and brain injury: therapeutic implications Trends Mol. Med. 8 2002 58 61 (Pubitemid 34094440)
34. D. Morgan, D.M. Diamond, P.E. Gottschall, K.E. Ugen, C. Dickey, J. Hardy, K. Duff, P. Jantzen, G. DiCarlo, D. Wilcock, K. Connor, J. Hatcher, C. Hope, M. Gordon, and G.W. Arendash A beta peptide vaccination prevents memory loss in an animal model of Alzheimer's disease Nature 408 2000 982 985 (Pubitemid 32101645)
35. P.R. Mouton Principles and Practices of Unbiased Stereology: An Introduction for Bioscientists 2002 The Johns Hopkins University Press Baltimore, Maryland
36. P.R. Mouton, M.E. Chachich, C. Quigley, E. Spangler, and D.K. Ingram Caloric restriction attenuates cortical amyloidosis in a double transgenic mouse model of Alzheimer's disease Neurosci. Lett. 464 2009 184 187
37. C. Nathan, N. Calingasan, J. Nezezon, A. Ding, M.S. Lucia, K. La Perle, M. Fuortes, M. Lin, S. Ehrt, N.S. Kwon, J. Chen, Y. Vodovotz, K. Kipiani, and M.F. Beal Protection from Alzheimer's-like disease in the mouse by genetic ablation of inducible nitric oxide synthase Nov 7 J. Exp. Med. 202 9 2005 1163 1169 Epub 2005 Oct 31 (Pubitemid 41586946)
38. E.S. Onaivi, H. Ishiguro, J.P. Gong, S. Patel, A. Perchuk, P.A. Meozzi, L. Myers, Z. Mora, P. Tagliaferro, E. Gardner, A. Brusco, B.E. Akinshola, Q.R. Liu, B. Hope, S. Iwasaki, T. Arinami, L. Teasenfitz, and G.R. Uhl Discovery of the presence and functional expression of cannabinoid CB2 receptors in the brain Ann. NY Acad. Sci. 1074 2006 514 536 (Pubitemid 44532857)
39. D.A. Pettit, M.P. Harrison, J.M. Olson, R.F. Spencer, and G.A. Cabral Immunohistochemical localization of the neural cannabinoid receptor in rat brain J. Neurosci. Res. 51 1998 391 402 (Pubitemid 28078470)
40. D. Piomelli, A. Giuffrida, A. Calignano, and F. Rodríguez de Fonseca The endocannabinoid system as a target for therapeutic drugs Trends Pharmacol. Sci. 21 2000 218 224 (Pubitemid 30331091)
41. B.G. Ramírez, C. Blázquez, T. Gómez del Pulgar, M. Guzmán, and M.L. de Ceballos Prevention of Alzheimer's disease pathology by cannabinoids: neuroprotection mediated by blockade of microglial activation J. Neurosci. 25 2005 1904 1913 (Pubitemid 40289395)
42. Richfield and Herkenham Selective vulnerability in Huntington's disease: preferential loss of cannabinoid receptors in lateral globus-pallidus Ann. Neurol. 36 1994 577 584 (Pubitemid 24309369)
43. J. Rogers, S. Webster, L.F. Lue, L. Brachova, W.H. Civin, M. Emmerling, B. Shivers, D. Walker, and P. McGeer Inflammation and Alzheimer's disease pathogenesis Neurobiol. Aging 17 1996 681 686 (Pubitemid 26348868)
44. P. Schubert, T. Ogata, C. Marchini, and S. Ferroni Glia-related pathomechanisms in Alzheimer's disease: a therapeutic target? Mech. Ageing Dev. 123 2001 47 57 (Pubitemid 32972258)
45. D.J. Selkoe Alzheimer's disease: genes, proteins, and therapy Physiol. Rev. 81 2001 741 766 (Pubitemid 32267077)
46. Shen and Thayer Cannabinoid receptor agonists protect cultured rat hippocampal neurons from excitotoxicity Mol. Pharmacol. 54 1998 459 462 (Pubitemid 28442938)
47. C. Sturchler-Pierrat, D. Abramowski, M. Duke, K.H. Wiederhold, C. Mistl, S. Rothacher, B. Ledermann, K. Bürki, P. Frey, P.A. Paganetti, C. Waridel, M.E. Calhoun, M. Jucker, A. Probst, M. Staufenbiel, and B. Sommer Two amyloid precursor protein transgenic mouse models with Alzheimer disease-like pathology Proc. Natl Acad. Sci. 94 1997 13287 13292 (Pubitemid 27518514)
48. T. Sugiura, S. Kondo, A. Sukagawa, S. Nakane, A. Shinoda, K. Itoh, A. Yamashita, and K. Waku 2-Arachidonoylglycerol: a possible endogenous cannabinoid receptor ligand in brain Biochem. Biophys. Res. Commun. 215 1 1995 89 97
49. J.C. Troncoso, R.R. Sukhov, C.H. Kawas, and V.E. Koliatsos In situ labeling of dying cortical neurons in normal aging and in Alzheimer's disease: correlations with senile plaques and disease progression J. Neuropathol. Exp. Neurol. 55 1996 1134 1142 (Pubitemid 26372790)
50. K. Tsou, S. Brown, M.C. Sañudo-Peña, K. Mackie, and J.M. Walker Immunohistochemical distribution of cannabinoid CB1 receptors in the rat central nervous system Neuroscience 83 1998 393 411 (Pubitemid 28062631)
51. G.W. Van Hoesen, B.T. Hyman, and A.R. Damasio Entorhinal cortex pathology in Alzheimer's disease Hippocampus 1 1991 1 8
52. Tanila H. Wang, J. Puolivali, I. Kadish, and T. Van Groen Gender differences in the amount and deposition of amyloid-beta in APPswe and PS1 double transgenic mice Neurobiol. Dis. 14 2003 318 327 (Pubitemid 37543511)
53. Q. Wang, J. Wu, M.J. Rowan, and R. Anwyl Beta-amyloid inhibition of long-term potentiation is mediated via tumor necrosis factor Eur. J. Neurosci. 22 11 2005 2827 2832 Dec (Pubitemid 41811280)
54. M.J. West, L. Slomianka, and H.J. Gunderson Unbiased stereological estimation of the total number of neurons in the subdivisions of the rat hippocampus using the optical fractionator Anat. Rec. 231 1991 482 497
55. T.M. Westlake, A.C. Howlett, T.I. Bonner, L.A. Matsuda, and M. Herkenham Cannabinoid receptor binding and messenger RNA expression in human brain: an in vitro receptor autoradiography and in situ hybridization histochemistry study of normal aged and Alzheimer's brains Neuroscience 63 1994 637 652 (Pubitemid 24360219)
56. H.M. Wisniewski, and R.D. Terry Morphology of the aging brain, human and animal Prog. Brain Res. 40 1973 167 186